RMQHX vs. BIPIX

Last updated Jun 3, 2026

RMQHX (Rydex Monthly Rebalance NASDAQ-100 2x Strategy H) and BIPIX (ProFunds Biotechnology UltraSector Fund) are both Leveraged Equities funds. Over the past 10 years, RMQHX returned 37.46%/yr vs 6.81%/yr for BIPIX. A 0.60 correlation means they provide meaningful diversification when combined. RMQHX charges 1.27%/yr vs 1.49%/yr for BIPIX.

Performance

RMQHX vs. BIPIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rydex Monthly Rebalance NASDAQ-100 2x Strategy H (RMQHX) and ProFunds Biotechnology UltraSector Fund (BIPIX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RMQHX achieves a 38.83% return, which is significantly higher than BIPIX's 11.63% return. Over the past 10 years, RMQHX has outperformed BIPIX with an annualized return of 37.46%, while BIPIX has yielded a comparatively lower 6.81% annualized return.

RMQHX

• 1D: 1.16%
• 1M: 19.81%
• YTD: 38.83%
• 6M: 35.00%
• 1Y: 84.57%
• 3Y*: 50.69%
• 5Y*: 26.53%
• 10Y*: 37.46%

BIPIX

• 1D: -3.48%
• 1M: 3.13%
• YTD: 11.63%
• 6M: 16.74%
• 1Y: 99.84%
• 3Y*: 7.19%
• 5Y*: 2.14%
• 10Y*: 6.81%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RMQHX vs. BIPIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RMQHX Rydex Monthly Rebalance NASDAQ-100 2x Strategy H	38.83%	33.90%	44.74%	115.89%	-59.96%	56.33%	101.06%	80.70%	-7.28%	69.79%
BIPIX ProFunds Biotechnology UltraSector Fund	11.63%	47.99%	-25.91%	9.55%	-13.43%	5.00%	19.94%	23.65%	-12.15%	34.71%

Correlation

The correlation between RMQHX and BIPIX is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.45
Correlation (3Y) Calculated over the trailing 3-year period	0.46
Correlation (5Y) Calculated over the trailing 5-year period	0.52
Correlation (10Y) Calculated over the trailing 10-year period	0.58
Correlation (All Time) Calculated using the full available price history since Jan 5, 2015	0.60

The correlation between RMQHX and BIPIX shifts across timeframes, from 0.45 (1 year) to 0.60 (all time), reflecting how their relationship changes across market environments.

Return for Risk

RMQHX vs. BIPIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RMQHX

RMQHX Risk / Return Rank: 68
RMQHX Sharpe Ratio Rank: 84
RMQHX Sortino Ratio Rank: 57
RMQHX Omega Ratio Rank: 57
RMQHX Calmar Ratio Rank: 77
RMQHX Martin Ratio Rank: 64

BIPIX

BIPIX Risk / Return Rank: 81
BIPIX Sharpe Ratio Rank: 88
BIPIX Sortino Ratio Rank: 72
BIPIX Omega Ratio Rank: 56
BIPIX Calmar Ratio Rank: 97
BIPIX Martin Ratio Rank: 94

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RMQHX vs. BIPIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Rydex Monthly Rebalance NASDAQ-100 2x Strategy H (RMQHX) and ProFunds Biotechnology UltraSector Fund (BIPIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RMQHX	BIPIX	Difference
Sharpe ratio Return per unit of total volatility	2.73	2.87	-0.14
Sortino ratio Return per unit of downside risk	3.18	3.55	-0.37
Omega ratio Gain probability vs. loss probability	1.42	1.42	0.00
Calmar ratio Return relative to maximum drawdown	3.47	6.78	-3.30
Martin ratio Return relative to average drawdown	12.59	20.90	-8.32
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RMQHX vs. BIPIX - Sharpe Ratio Comparison

The current RMQHX Sharpe Ratio is 2.73, which is comparable to the BIPIX Sharpe Ratio of 2.87. The chart below compares the historical Sharpe Ratios of RMQHX and BIPIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	RMQHX	BIPIX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.73	2.87	-0.14
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.58	0.05	+0.52
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.81	0.19	+0.62
Sharpe Ratio (All Time) Calculated using the full available price history	0.75	0.16	+0.60

Drawdowns

RMQHX vs. BIPIX - Drawdown Comparison

The maximum RMQHX drawdown since its inception was -63.21%, smaller than the maximum BIPIX drawdown of -84.51%. Use the drawdown chart below to compare losses from any high point for RMQHX and BIPIX.

Drawdown Indicators

	RMQHX	BIPIX	Difference
Max Drawdown Largest peak-to-trough decline	-63.21%	-84.51%	+21.30%
Max Drawdown (1Y) Largest decline over 1 year	-24.97%	-15.15%	-9.82%
Max Drawdown (3Y) Largest decline over 3 years	-42.46%	-59.50%	+17.04%
Max Drawdown (5Y) Largest decline over 5 years	-63.21%	-63.86%	+0.65%
Max Drawdown (10Y) Largest decline over 10 years	-63.21%	-63.86%	+0.65%
Current Drawdown Current decline from peak	0.00%	-10.56%	+10.56%
Average Drawdown Average peak-to-trough decline	-12.87%	-37.23%	+24.36%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.89%	4.91%	+1.98%

Volatility

RMQHX vs. BIPIX - Volatility Comparison

The current volatility for Rydex Monthly Rebalance NASDAQ-100 2x Strategy H (RMQHX) is 8.62%, while ProFunds Biotechnology UltraSector Fund (BIPIX) has a volatility of 12.45%. This indicates that RMQHX experiences smaller price fluctuations and is considered to be less risky than BIPIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RMQHX	BIPIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.62%	12.45%	-3.83%
Volatility (6M) Calculated over the trailing 6-month period	24.34%	29.59%	-5.25%
Volatility (1Y) Calculated over the trailing 1-year period	32.21%	37.82%	-5.61%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	46.22%	39.59%	+6.63%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	46.44%	36.31%	+10.13%

RMQHX vs. BIPIX - Expense Ratio Comparison

RMQHX has a 1.27% expense ratio, which is lower than BIPIX's 1.49% expense ratio.

Dividends

RMQHX vs. BIPIX - Dividend Comparison

RMQHX's dividend yield for the trailing twelve months is around 25.05%, more than BIPIX's 0.33% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
BIPIX ProFunds Biotechnology UltraSector Fund	0.33%	0.37%	0.23%	6.69%	0.00%	0.79%	12.09%	3.26%	5.52%	7.19%
RMQHX Rydex Monthly Rebalance NASDAQ-100 2x Strategy H	25.05%	34.77%	25.22%	3.66%	0.00%	2.13%	5.17%	0.10%	0.00%	0.00%

Frequently Asked Questions

Can I hold both RMQHX and BIPIX in my portfolio?

RMQHX and BIPIX have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RMQHX or BIPIX?

BIPIX has higher volatility (12.45%) compared to RMQHX (8.62%). In terms of maximum drawdown, RMQHX dropped -63.21% vs BIPIX's -84.51%.

Which has better risk-adjusted returns?

BIPIX currently has the higher Sharpe Ratio (2.87 vs 2.73), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.